SELLAS Life Sciences Group, Inc. SLS Change in Accrued Liabilities
Change in Accrued Liabilities at other companies
Other financials
Where this comes from
Reported directly by SELLAS Life Sciences Group, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccruedLiabilities.
The official record: SELLAS Life Sciences Group, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about SELLAS Life Sciences Group, Inc.'s change in accrued liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is SELLAS Life Sciences Group, Inc.'s change in accrued liabilities?
- SELLAS Life Sciences Group, Inc. (SLS) reported change in accrued liabilities of -$1.26M in Q1 2026.
- How has SELLAS Life Sciences Group, Inc.'s change in accrued liabilities changed year-over-year?
- SELLAS Life Sciences Group, Inc.'s change in accrued liabilities increased by 56.3% year-over-year, from -$2.9M to -$1.26M.
- What is the long-term trend for SELLAS Life Sciences Group, Inc.'s change in accrued liabilities?
- Over 2 years (2021 to 2023), SELLAS Life Sciences Group, Inc.'s change in accrued liabilities has grown at a 41.2% compound annual growth rate (CAGR), from $727K to $1.45M.
- What does change in accrued liabilities mean?
- Change in accrued expenses and other current liabilities, reflecting timing differences between expense recognition and cash payment.